FREE CLICK & COLLECT SERVICE AVAILABLE | SPEND OVER €10 FOR FREE DELIVERY

Health Care Expenditures, Innovation, and Demographic Change

by Yasemin Ilgin | 05 August 2008
PAPERBACK
Category: Economics
Synopsis
In the focus of the health care market analyses usually are increasing health care expenditures (HCE) and their future development. Considering these increasing HCE the price regulation measures are applied in the relevant pharmaceutical market to contain these increases. Some believe that HCE mainly rise due to medico-technical and pharmaceutical innovation and ageing. After reviewing international measures of price regulation, empirical studies examine the relation between innovation and ageing. The main conclusions are: the ageing effect causes rising expenditures on pharmaceuticals as well as increasing pharmaceutical innovations instrumented either as patent applications or new drug approvals; the research and development expenditures of the pharmaceutical industry lead to rising expenditures on pharmaceuticals but decreasing overall HCE; additionally, decreasing mortality is found to increase HCE. These results do not support the medicalisation hypothesis of a disproportional increase of HCE with rising share of elderly persons. Therefore, the overall impact of pharmaceutical progress on HCE is not straightforward. Consequently, predominating conclusions and political implications should be reconsidered.
€37.80
113 Reward Points
Currently out of stock
Delivery in 5-7 Days
Eligible for free delivery

Any purchases for more than €10 are eligible for free delivery anywhere in the UK or Ireland!

Synopsis
In the focus of the health care market analyses usually are increasing health care expenditures (HCE) and their future development. Considering these increasing HCE the price regulation measures are applied in the relevant pharmaceutical market to contain these increases. Some believe that HCE mainly rise due to medico-technical and pharmaceutical innovation and ageing. After reviewing international measures of price regulation, empirical studies examine the relation between innovation and ageing. The main conclusions are: the ageing effect causes rising expenditures on pharmaceuticals as well as increasing pharmaceutical innovations instrumented either as patent applications or new drug approvals; the research and development expenditures of the pharmaceutical industry lead to rising expenditures on pharmaceuticals but decreasing overall HCE; additionally, decreasing mortality is found to increase HCE. These results do not support the medicalisation hypothesis of a disproportional increase of HCE with rising share of elderly persons. Therefore, the overall impact of pharmaceutical progress on HCE is not straightforward. Consequently, predominating conclusions and political implications should be reconsidered.
€37.80
113 Reward Points
Currently out of stock
Delivery in 5-7 Days
Eligible for free delivery

Any purchases for more than €10 are eligible for free delivery anywhere in the UK or Ireland!


Product Details

ISBN - 9783631581544
Format - PAPERBACK
Publisher -
Published - 05/08/2008
Categories - All, Books, Business Computers, Finance, Economics
No. of Pages - 110
Weight - 190
Edition - New edition
Series - - Not Available
Page Size - 21
Language - en-US
Readership Age - Not Available
Table of Contents - Not Available

Delivery And Returns

Please Note: Items in our extended range may take longer to deliver. Delivery in 5-7 Days

Place an order for over €10 to receive free delivery to anywhere in Ireland and the UK! See our Delivery Charges section below for a full breakdown of shipping costs for all destinations.

 

Delivery Charges

  Ireland & UK* Europe & USA Australia & Canada Rest of World
Under €10 €3.80 €10 €15 €25
Over €10
Free €10 €15 €25

*Free delivery on all orders over €10 - only applies to order total.

All orders will be delivered by An Post.